Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1673541000001117 | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1673551000001119 | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device (Sandoz Ltd) | Is a | True | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device | Inferred relationship | Existential restriction modifier | |
Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Has VMP | True | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets